ASTRO Abstract Reviewer Training

The ASTRO Abstract Reviewer training is an online program designed to clarify abstract study designs in order to enable the reviewers to score more predictably and homogenously.

2024 Advocacy Update

The 2024 ASTRO Advocacy Update provides participants with an opportunity to better understand how ASTRO advocates for policies that benefit radiation oncology on Capitol Hill.

2024 ASTRO Coding and Coverage Seminar -SRS and SBRT

Topics Included:

2024 ASTRO Coding and Coverage Seminar - Brachytherapy and Radiopharmaceuticals

Topics Included:

1. Brachytherapy
Participants will learn about the radiation therapy modality of brachytherapy. Codes specific to this modality are addressed. ASTRO’s Brachytherapy Model Policy is reviewed in detail.

2024 ASTRO Coding and Coverage Seminar - Protons, 3-D and IMRT

Topics Included:

1. Proton Beam Therapy
Participants will learn about the proton beam therapy (PBT) radiation modality and codes. ASTRO’s Proton Beam Therapy Model Policy is reviewed in detail. 

2024 ASTRO Coding and Coverage Seminar - Radiation Oncology Coding Landscape and Prior Authorization

Topics Included:

eContouring for Celiac Plexus Radiosurgery

This contouring activity features celiac plexus radiosurgery, a new technique for pain control in pancreatic cancer. The results of an international phase II study were positive (presented at the 2022 ASTRO Annual Meeting as a late-breaking oral abstract).

Navigating Medical Insurance Delays and Denials: Insights from Patients, ASTRO and the Press

Navigating medical insurance for radiation treatment in the United States is frustrating and complex, often resulting in disappointment for patients, delays in care, and denials of standard of care treatment.

Practical Elements of a Radiopharmaceutical Program: Findings from ASTRO's Safety White Paper

Despite the rapid advancements, there exists a gap in the integration of radiopharmaceutical therapy within radiation oncology practices.

Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results

Radiotherapy plays an important role as a consolidation treatment after systemic therapy, either to shorten the course of systemic therapy and reduce hematological, cardiac and fertility toxicity or to reduce the risk of relapse e.g., for bulky masses.

Pages

Subscribe to RSS - Sessions onDemand